These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


408 related items for PubMed ID: 25247665

  • 1. Guidelines for diagnosis and management of Beta-thalassemia intermedia.
    Karimi M, Cohan N, De Sanctis V, Mallat NS, Taher A.
    Pediatr Hematol Oncol; 2014 Oct; 31(7):583-96. PubMed ID: 25247665
    [Abstract] [Full Text] [Related]

  • 2. Contemporary approaches to treatment of beta-thalassemia intermedia.
    Taher AT, Musallam KM, Karimi M, Cappellini MD.
    Blood Rev; 2012 Apr; 26 Suppl 1():S24-7. PubMed ID: 22631038
    [Abstract] [Full Text] [Related]

  • 3. Thalassemia intermedia: revisited.
    Taher A, Isma'eel H, Cappellini MD.
    Blood Cells Mol Dis; 2006 Apr; 37(1):12-20. PubMed ID: 16737833
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Insight onto the pathophysiology and clinical complications of thalassemia intermedia.
    Cappellini MD, Musallam KM, Taher AT.
    Hemoglobin; 2009 Apr; 33 Suppl 1():S145-59. PubMed ID: 20001620
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Optimal management of β thalassaemia intermedia.
    Taher AT, Musallam KM, Cappellini MD, Weatherall DJ.
    Br J Haematol; 2011 Mar; 152(5):512-23. PubMed ID: 21250971
    [Abstract] [Full Text] [Related]

  • 10. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A, Kati M, Tsironi M, Polonifi E, Farmakis D.
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Beta-thalassemia: clinical manifestations].
    Perrimond H.
    Bull Soc Pathol Exot; 2001 May; 94(2):92-4. PubMed ID: 11475035
    [Abstract] [Full Text] [Related]

  • 16. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
    Matter RM, Abdelmaksoud AA, Shams MA, Bebawy EK.
    Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
    [Abstract] [Full Text] [Related]

  • 17. Thalassemia intermedia today: should patients regularly receive transfusions?
    Aessopos A, Kati M, Meletis J.
    Transfusion; 2007 May; 47(5):792-800. PubMed ID: 17465943
    [Abstract] [Full Text] [Related]

  • 18. Beta-Thalassemia Intermedia: A Single Thalassemia Center Experience from Northeastern Iraq.
    Amin SS, Jalal SD, Ali KM, Mohammed AI, Rasool LK, Osman TJ.
    Biomed Res Int; 2020 May; 2020():2807120. PubMed ID: 32190657
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management.
    Vichinsky E.
    Curr Med Res Opin; 2016 May; 32(1):191-204. PubMed ID: 26479125
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.